GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Ampio Pharmaceuticals AMPE · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.18

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Ampio Pharmaceuticals

Our reporting

We have not reported on Ampio Pharmaceuticals yet.

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -6.00 a share on revenue of $245,000.

Past results

Reported against what analysts expected

27 Mar 202414 Nov 20238 Aug 20238 May 202327 Mar 202314 Nov 2022
Earnings per share-2.48-1.53-1.80-5.20-3.60-10.00
Forecast—-6.00-6.00-6.00-6.00-0.02
Revenue$245,000—————

Key events

  1. 12 Sept 202320-to-1 reverse split
  2. 10 Nov 202215-to-1 reverse split
  3. 19 May 2011Listed
  4. 1 Aug 20083.5-to-1 reverse split

Ampio Pharmaceuticals in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.